This month, Ann LaCasce, MD, weighs in about recommending a bone marrow biopsy and whether or not to give G-CSF.
A 44-year-old male with no significant past medical history presented after having palpated on himself supraclavicular adenopathy. A biopsy showed Hodgkin lymphoma, nodular sclerosis subtype. A CT showed neck and hilar adenopathy, with a maximum size of 2-3 cm. A PET scan also showed bone disease, as well as supraclavicular, mediastinal, and right hilar adenopathy as described above. Would you recommend a bone marrow biopsy to complete staging? The CBC shows no cytopenias, and the stage is already stage IV disease. I don’t see how it will change the management. Would you give G-CSF? There is conflicting evidence regarding its association with bleomycin toxicity of the lung.
EXPERTS MAKE THE CALL
I agree that a bone marrow biopsy will not change therapy and could easily miss the disease. We don’t give G-CSF unless a patient develops febrile neutropenia or has recurrent infections, in which case we would use as little G-CSF as possible (usually on days 5-8 or 9).
Disclaimer: ASH does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this article is solely at your own risk.